SCHEMBL22304501

SCHEMBL22304501

O=C1COC(c2ccc(F)cc2)=NN1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAOB P27338 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22304755 0.98 MAOB (0.61) MAOB
SCHEMBL22304669 0.85 MAOB (0.59) MAOB
SCHEMBL22288402 0.85 PDE3B (0.61) MAOB
SCHEMBL22288623 0.84 MAOB (0.63) MAOB
SCHEMBL22304647 0.83 MAOB (0.57) MAOB
SCHEMBL7287552 0.83 MAOB (0.61) MAOB
SCHEMBL22304511 0.82 PDE3B (0.61) MAOB
SCHEMBL517561 0.82 MAOB (0.74) MAOB
SCHEMBL22288965 0.82 MAOB (0.56) MAOB
SCHEMBL22304848 0.81 PDE3B (0.58) MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020157201-A1 OXADIAZINONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-06 WO disclosed